Skip to main content
Fig. 2 | Journal of Patient-Reported Outcomes

Fig. 2

From: Psychometric validation of the 1-month recall Uterine Fibroid Symptom and Health-Related Quality of Life questionnaire (UFS-QOL)

Fig. 2

Known groups validity: UFS-QOL scale scores by achievement of absence of bleeding and controlled bleeding after 12 weeks of treatment in (a) VENUS I and (b) VENUS II: per protocol population (patient-reported outcome approach). p < 0.001 for comparisons of absence of bleeding versus no absence of bleeding, and controlled bleeding versus no controlled bleeding, for all scales; error bars represent standard deviation. HRQoL health-related quality of life; UFS-QOL Uterine Fibroid Symptom and Health-Related Quality of Life questionnaire

Back to article page
\